Table 2 Summary of the potential biomarkers in kidney extracts from db/db mice and wildtype mice.
From: Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice
δ1H(ppm) | metabolites | metabolism pathway | wildtype mice | db/db mice |
|---|---|---|---|---|
1.342 | Lactate | Glycolysis | 38.78 ± 0.76 | 53.27 ± 2.42** |
1.919 | Acetate | Fatty acids β-oxidation | 3.31 ± 0.09 | 1.93 ± 0.09** |
1.206 | 3-hydroxybutyrate | Ketogenesis | 3.39 ± 0.20 | 1.52 ± 0.05** |
3.037 | Creatinine | Serinolysis | 7.59 ± 0.22 | 4.50 ± 0.28** |
3.204 | Choline | Methylamine metabolism | 21.12 ± 1.02 | 14.12 ± 0.87** |
3.275 | TMAO | Methylamine metabolism | 7.52 ± 0.13 | 9.41 ± 0.28** |
3.545 | myo-Inositol | Lipid metabolism | 27.45 ± 0.26 | 28.47 ± 0.34* |
2.372 | Glutamate | Amino acid metabolism | 22.23 ± 0.42 | 12.68 ± 0.64** |
3.557 | Glycine | Amino acid metabolism | 16.05 ± 0.37 | 8.10 ± 0.52** |
6.909 | Tyrosine | Amino acid metabolism | 0.44 ± 0.01 | 0.39 ± 0.01* |
5.809 | Uracil | Pyrimidine metabolism | 0.22 ± 0.01 | 0.16 ± 0.01** |
5.92 | Uridine | Pyrimidine metabolism | 0.88 ± 0.02 | 0.73 ± 0.04** |
5.94 | GTP | Purine metabolism | 0.55 ± 0.01 | 0.47 ± 0.01** |